Furthermore, PD-L1 may be a target of HIF2a in clear cell renal cell carcinoma (ccRCC) cells in which the tumor-suppressor pVHL was abrogated. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.